Sumitomo Mitsui Trust Group Inc. Sells 69,021 Shares of Corteva, Inc. $CTVA

Key Points

• Sumitomo Mitsui Trust Group trimmed its Corteva stake by 3.2% in Q4, selling 69,021 shares and now holds 2,064,508 shares (~0.31% of the company) valued at about $138.38 million.
• Insider Brian Titus sold 8,311 shares on Feb. 20 at an average $76.55, cutting his holding by 50.67%; institutional investors collectively own about 81.54% of Corteva while insiders hold 0.15%.
• Corteva trades with a market cap of ~$56.0B and a P/E of ~52.8, reported Q results with EPS $0.22 and set FY26 guidance of $3.45–$3.70; it pays a quarterly dividend of $0.18 (0.9% yield) and carries an average analyst rating of “Moderate Buy” with a $83.57 price target.

Sumitomo Mitsui Trust Group Inc. cut its position in Corteva, Inc. (NYSE:CTVA - Free Report) by 3.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,064,508 shares of the company's stock after selling 69,021 shares during the quarter. Sumitomo Mitsui Trust Group Inc. owned about 0.31% of Corteva worth $138,384,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. State Street Corp grew its stake in shares of Corteva by 3.6% in the third quarter. State Street Corp now owns 35,280,805 shares of the company's stock valued at $2,386,041,000 after buying an additional 1,230,074 shares in the last quarter. Franklin Resources Inc. grew its stake in shares of Corteva by 5.9% in the third quarter. Franklin Resources Inc. now owns 18,731,627 shares of the company's stock valued at $1,266,820,000 after buying an additional 1,051,389 shares in the last quarter. Northern Trust Corp grew its stake in shares of Corteva by 1.8% in the third quarter. Northern Trust Corp now owns 11,169,284 shares of the company's stock valued at $755,379,000 after buying an additional 194,728 shares in the last quarter. Legal & General Group Plc grew its stake in shares of Corteva by 14.3% in the third quarter. Legal & General Group Plc now owns 5,753,982 shares of the company's stock valued at $389,142,000 after buying an additional 720,469 shares in the last quarter. Finally, Alliancebernstein L.P. grew its stake in shares of Corteva by 3.0% in the third quarter. Alliancebernstein L.P. now owns 4,381,340 shares of the company's stock valued at $296,310,000 after buying an additional 125,690 shares in the last quarter. 81.54% of the stock is owned by institutional investors.

Insider Buying and Selling at Corteva

In other news, insider Brian Titus sold 8,311 shares of Corteva stock in a transaction on Friday, February 20th. The stock was sold at an average price of $76.55, for a total transaction of $636,207.05. Following the completion of the sale, the insider owned 8,090 shares of the company's stock, valued at approximately $619,289.50. This trade represents a 50.67% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.15% of the company's stock.

Corteva Trading Down 0.4%

CTVA stock opened at $83.47 on Tuesday. Corteva, Inc. has a one year low of $58.58 and a one year high of $85.63. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 0.96. The stock has a market cap of $56.04 billion, a price-to-earnings ratio of 52.83, a price-to-earnings-growth ratio of 2.86 and a beta of 0.68. The company has a fifty day moving average price of $78.94 and a two-hundred day moving average price of $70.71.

Corteva (NYSE:CTVA - Get Free Report) last posted its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, hitting analysts' consensus estimates of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The company had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $4.23 billion. During the same quarter last year, the firm earned $0.32 earnings per share. The company's revenue was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities analysts anticipate that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, March 16th. Stockholders of record on Monday, March 2nd were issued a dividend of $0.18 per share. The ex-dividend date of this dividend was Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva's dividend payout ratio (DPR) is currently 45.57%.

Analyst Upgrades and Downgrades

A number of research firms have commented on CTVA. The Goldman Sachs Group reaffirmed a "buy" rating and set a $88.00 price objective on shares of Corteva in a research report on Thursday, February 5th. BNP Paribas Exane lifted their price objective on shares of Corteva from $72.00 to $74.00 in a research report on Monday, March 9th. UBS Group lifted their price objective on shares of Corteva from $80.00 to $88.00 and gave the stock a "neutral" rating in a research report on Thursday, April 9th. Zacks Research cut shares of Corteva from a "strong-buy" rating to a "hold" rating in a research report on Friday, February 20th. Finally, Citigroup lifted their price objective on shares of Corteva from $74.00 to $80.00 and gave the stock a "neutral" rating in a research report on Thursday, February 5th. Fourteen research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $83.57.

About Corteva

Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.